OFFICES
- New York - P: (212) 351-3400
- San Francisco - P: (415) 573-1900
- Washington, D.C. - P: (202) 451-4900
Desmarais LLP Wins $57M Jury Verdict for Ravgen in Prenatal Genetic Testing Patent Trial
Following a weeklong trial, Desmarais LLP secured a $57 million jury verdict on behalf of the Maryland-based biotech firm Ravgen and its prenatal genetic testing technology against the Austin-based lab testing company Natera.
MOREFEATURED PARTNER
Bindu Donovan
Bindu Donovan is a partner in Desmarais LLP’s Life Sciences Practice, with more than 25 years of experience litigating high stakes intellectual property disputes in...
ALL